Return to search results.
Complete title: A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of DCDT2980S in Combination with Rituximab or DCDS4501A in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
|Research Study Number||2649.00|
|Principal Investigator||Oliver Press, MD, PhD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Lymphoma; Lymphoproliferative Disease; Non-Hodgkin's Lymphoma (NHL)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.